The age of onset ranges from six to 22 years old, but 50% of cases present between 13 and 16 years of age. Valproate is widely regarded as the first‐line therapy in JME owing to its broad spectrum of activity. [cochranelibrary.com]

Neurotoxicity scores did not substantially differ between treatment groups. [cochranelibrary.com]